• English
    • Norsk
  • English 
    • English
    • Norsk
  • Administration
View Item 
  •   Home
  • Det matematisk-naturvitenskapelige fakultet
  • Farmasøytisk institutt
  • Farmasøytisk institutt
  • View Item
  •   Home
  • Det matematisk-naturvitenskapelige fakultet
  • Farmasøytisk institutt
  • Farmasøytisk institutt
  • View Item
JavaScript is disabled for your browser. Some features of this site may not work without it.

New concepts for personalized immunosuppression in the transplanted patient

Klaasen, Rolf Anton
Doctoral thesis
View/Open
PhD-Klaasen-2020.pdf (2.848Mb)
Year
2020
Permanent link
http://urn.nb.no/URN:NBN:no-79524

Metadata
Show metadata
Appears in the following Collection
  • Farmasøytisk institutt [1380]
Abstract
After transplantation patients receive individualized immunosuppressive treatment based on drug concentrations to hinder rejection of the transplant. This thesis aimed to develop and apply alternative methods of measuring the immunosuppressants tacrolimus, belatacept and mycophenolic acid.

Tacrolimus exerts its effect inside lymphocytes but is measured in whole blood. An assay developed in this thesis showed that concentrations inside lymphocytes was only partially related to the whole blood concentration. It was also shown that the amount of tacrolimus that distributes to lymphocytes after dose may decrease during the first year after transplantation.

A belatacept assay was developed and used to show that belatacept has a stable pharmacokinetic profile, but heavier patients may have a higher drug exposure since belatacept dose is adjusted according to body mass.

The pharmacodynamic response of mycophenolic acid was measured in resting and ex vivo stimulated lymphocytes. Mycophenolic acid had a stronger effect on stimulated cells, but in a cohort of transplant patient both resting and stimulated cells appeared to become less sensitive during the first year after transplantation.
List of papers
Paper I. RA Klaasen, S Bergan, S Bremer, L Daleq, AM Andersen, K Midtvedt, MH Skauby, NT Vethe. Longitudinal Study of Tacrolimus in Lymphocytes During the First Year After Kidney Transplantation. Ther Drug Monit 2018; 40: 558-566. doi: 10.1097/FTD.0000000000000539. The article is not available in DUO due to publisher restrictions. The published version is available at: https://doi.org/10.1097/FTD.0000000000000539
Paper II. RA Klaasen, EJ Egeland, J Chan, K Midtvedt, K, M Svensson, N Bolstad, B Fellstrom, H Haldaas, A Åsberg, S Bergan, NT Vethe, DJ Warren. A Fully Automated Method for the Determination of Serum Belatacept and Its Application in a Pharmacokinetic Investigation in Renal Transplant Recipients. Ther Drug Monit 2019; 41: 11-18. doi: 10.1097/FTD.0000000000000580. The article is not available in DUO due to publisher restrictions. The published version is available at: https://doi.org/10.1097/FTD.0000000000000580
Paper III. RA Klaasen, S Bergan, S Bremer, K Hole, C Nordahl, AM Andersen, K Midtvedt, MH Skauby, NT Vethe. Pharmacodynamic assessment of mycophenolic acid in resting and activated target cell population during the first year after renal transplantation. Br J Clin Pharmacol 2019; published online ahead of print, 2020 Jan 11. DOI: 10.1111/bcp.14218. The article is included in the thesis. Also available at: https://doi.org/10.1111/bcp.14218
 
Responsible for this website 
University of Oslo Library


Contact Us 
duo-hjelp@ub.uio.no


Privacy policy
 

 

For students / employeesSubmit master thesisAccess to restricted material

Browse

All of DUOCommunities & CollectionsBy Issue DateAuthorsTitlesThis CollectionBy Issue DateAuthorsTitles

For library staff

Login
RSS Feeds
 
Responsible for this website 
University of Oslo Library


Contact Us 
duo-hjelp@ub.uio.no


Privacy policy